Literature DB >> 30690191

Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome.

Nisha Tiwari1, Shikha Pasrija2, Sandhya Jain1.   

Abstract

OBJECTIVES: 1. To study the efficacy of exercise in improving clinical symptoms, anthropometry, glucose tolerance and laboratory profile in women with Polycystic ovarian syndrome. 2. To study the combined efficacy of exercise and metformin on above parameters in women with polycystic ovary syndrome. STUDY
DESIGN: A Randomised double blinded placebo controlled trial was performed at a district hospital in New Delhi. Sixty six women were included in the study. Block randomisation was done to divide the women into two groups. Women were treated with fixed exercise schedule along with oral placebo in Group A and exercise with oral metformin in Group B. Outcomes stated in objectives were studied and statistically analysed. Quantitative variables were compared using unpaired t-test and Paired t-test within the groups across follow-ups. Qualitative variable has been compared using Chi-Square test /Fisher's exact test.
RESULTS: In Group A and B significant improvement was noted in menstrual cycles, mean waist circumference, mean waist-hip ratio and body mass index. The mean weight loss was 0.78 ± 0.19 kg and 1.71 ± 0.19 kg in group A and B respectively after 3 months. The mean weight loss was 1.08 ± 0.30 kg and 1.71 ± 0.19 kg in group A and B respectively. The mean difference in modified Ferriman Gallwey score at 0, 3 and 6 months were statistically significant in both groups. On comparing group A with group B at 6 months, significant improvement was found in menstrual cycle symptoms (55.17% vs 83.33%), mean weight loss (1.08 kg vs 2.5 kg), waist circumference reduction (2.56 cm vs 4.75 cm) and change in mean waist hip ratio (0.02 vs 0.04). Significant changes were noted in OGTT and Serum testosterone level at 6 months in Group B, but not in Group A. Statistically no significant differences were found in acne, acanthosis nigricans and other biochemical parameters.
CONCLUSION: Regular exercise should be recommended for the women with PCOS. It results in statistically significant improvement in menstrual cycle pattern, hirsutism, body mass index, weight, waist circumference waist-hip ratio. Addition of metformin resulted in added benefits on menstrual cycle, hirsutism, weight, body mass index, waist circumference, waist hip ratio, serum testosterone and Oral Glucose Tolerance Test (OGTT).
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exercise; Metformin; Polycystic ovarian syndrome

Mesh:

Substances:

Year:  2019        PMID: 30690191     DOI: 10.1016/j.ejogrb.2018.12.021

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

Review 1.  The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yuanyuan Guan; Dongjun Wang; Huaien Bu; Tieniu Zhao; Hongwu Wang
Journal:  Int J Endocrinol       Date:  2020-09-16       Impact factor: 3.257

2.  The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.

Authors:  Mohamed Abdel-Maboud; Amr Menshawy; Elfatih A Hasabo; Mohamed Ibrahim Abdelraoof; Mohamed Alshandidy; Muhammad Eid; Esraa Menshawy; Oumaima Outani; Ahmed Menshawy
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

3.  Long-Term Moderate Exercise Combined with Metformin Treatment Induces an Hormetic Response That Prevents Strength and Muscle Mass Loss in Old Female Wistar Rats.

Authors:  David Hernández-Álvarez; Beatriz Mena-Montes; Rafael Toledo-Pérez; Gibrán Pedraza-Vázquez; Stefanie Paola López-Cervantes; Alfredo Morales-Salazar; Edith Hernández-Cruz; Roberto Lazzarini-Lechuga; Roman Royer Vázquez-Cárdenas; Silvia Vilchis-DeLaRosa; Pedro Posadas-Rodríguez; Roberto Santín-Márquez; Oscar Rosas-Carrasco; Alejandra Ibañez-Contreras; Adriana Alarcón-Aguilar; Norma Edith López-Díazguerrero; Armando Luna-López; Mina Königsberg
Journal:  Oxid Med Cell Longev       Date:  2019-11-11       Impact factor: 6.543

4.  Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.

Authors:  Hsuan Yen; Yu-Tung Chang; Fui-Jun Yee; Yu-Chen Huang
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

Review 5.  Polycystic Ovary Syndrome and Gender Identity.

Authors:  Minghao Liu; Swetha Murthi; Leonid Poretsky
Journal:  Yale J Biol Med       Date:  2020-09-30

6.  Chronic Embryo-Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses.

Authors:  Joanne L Parrott; Victoria E Restivo; Karen A Kidd; Juliet Zhu; Kallie Shires; Stacey Clarence; Hufsa Khan; Cheryl Sullivan; Grazina Pacepavicius; Mehran Alaee
Journal:  Environ Toxicol Chem       Date:  2021-06-02       Impact factor: 4.218

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.